Mayer Eldon C. III
- SEC CIK
- 0001686952
No open-market purchases or sales filed in the past year.
Current role at each company
- EIGR Eiger BioPharmaceuticals, Inc.Ex VP & Chief Commerc. Officeras of Mar 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mayer Eldon C. III as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2023 (view filing) | Mar 17 | 4 days | Mayer Eldon C. IIIEx VP & Chief Commerc. Officer | SSale | −4.39K | $1.07 | −$4.70K | −7.3%56.1K after | 2 lots |
| Mar 14, 2022 (view filing) | Mar 14 | Same day | Mayer Eldon C. IIIEx VP & Chief Commerc. Officer | SSale | −1.66K | $5.60 | −$9.28K | −2.7%60.5K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Mayer Eldon C. IIIEx VP & Chief Commerc. Officer | SSale | −1.56K | $4.95 | −$7.72K | −3.3%46.1K after |